| Address:
|
9900 CAVENDISH BLVD., SUITE 306
ST. LAURENT |
| City: |
QUEBEC CANADA |
|
State: |
|
|
Zip Code: |
H4M 2V2 |
| Telephone: |
514-332-3222 |
|
Description of Business
|
Primary SIC Code:
2835 |
| (As filed with the SEC)
|
|
|
Nymox Pharmaceutical Corporation was incorporated under the Canada Business
Corporations Act in May, 1995 to acquire all of the common shares of DMS
Pharmaceutical Inc., a private Corporation which had been carrying on research
and development since 1989 on diagnostics and drugs for brain disorders and
diseases of the aged with an emphasis on Alzheimer's disease. Nymox has two
subsidiaries: one wholly-owned subsidiary named Nymox Corporation and the other
a majority owned subsidiary named Serex, Inc., acquired in 2000. Both
subsidiaries are based in the same building in Hasbrouck Heights, New Jersey.
Nymox Corporation conducts some research and development, while Serex conducts
research and development, and some of the manufacturing for NicAlertT and
TobacAlertT.
Nymox's principal executive offices are located at:
Nymox Pharmaceutical Corporation
9900 Cavendish Boulevard, Suite 306, St. ... More ... |
| Date |
12-mos
Rolling EPS |
Dividend |
P/E
Ratio |
| 09/2011 | -0.32 | NA | N/E | | 06/2011 | -0.33 | NA | N/E | | 03/2011 | -0.32 | NA | N/E | | 12/2010 | -0.22 | NA | N/E | | 09/2010 | -0.20 | NA | N/E | | 06/2010 | -0.20 | NA | N/E | | 03/2010 | -0.18 | NA | N/E | | 12/2009 | -0.17 | NA | N/E |
Key Financial Ratios and Statistics |
FYE:
12/31 |
| Profitability |
2010 |
Leverage |
2010 |
| Net Inc/Comm Equity | -0.10 | Total Liab/Total Assets | 1.15 | | Net Inc/Total Assets | -0.52 | Total Liab/Inv Cap | 1.87 | | Net Inc/Inv Cap | -0.84 | Total Liab/Comm Equity | 0.23 | | Pretax Inc/Net Sales | -10.04 | Interest Coverage Ratio | -981.77 | | Net Inc/Net Sales | -10.04 | Curr Debt/Equity | NA | | Cash Flow/Net Sales | 11.35 | LTD/Equity | NA | | SG&A/NetSales | 3.99 | Total Debt/Equity | NA |
| Asset Utilization
|
|
Liquidity |
|
| Net Receivables Turnover | 2.23 | Quick Ratio | 2.59 | | Inventory Turnover | 11.77 | Current Ratio | 2.59 | | Inventory Day Sales | 0.05 | Net Rec/Curr Assets | 0.02 | | Net Sales/Work Cap | 0.08 | Inv/Curr Assets | 0.00 | | Net Sales/PP&E | 47.02 | | |
Income Statement (Millions) |
| |
12/31/2010
|
12/31/2009
|
12/31/2008
|
12/31/2007
|
|
Total Revenues(Net Sales)
|
0.69
|
0.42
|
0.43
|
0.41
|
|
Cost of Goods Sold
|
0.32
|
0.25
|
0.26
|
0.24
|
|
Selling & Admin Exps
|
2.76
|
2.02
|
2.18
|
2.22
|
|
Operating Income
|
-6.95
|
-5.13
|
-4.58
|
-5.29
|
|
Interest Exp
|
0.01
|
0.00
|
0.01
|
0.02
|
|
Pretax Income
|
-6.96
|
-5.13
|
-4.59
|
-5.29
|
|
Other Income
|
NA
|
NA
|
NA
|
0.02
|
|
Net Income Bef Extraordinary ...
|
NA
|
NA
|
NA
|
NA
|
|
Net Income
|
-6.96
|
-5.13
|
-4.59
|
-5.29
|
|
Assets
|
12/31/2010
|
12/31/2009
|
12/31/2008
|
12/31/2007
|
|
Cash & Short Term Investments
|
13.17
|
0.67
|
0.28
|
0.27
|
|
Receivables - Total
|
0.28
|
0.34
|
0.17
|
0.13
|
|
Inventories - Total
|
0.02
|
0.04
|
0.03
|
0.03
|
|
Total Current Assets
|
13.47
|
1.07
|
0.48
|
0.43
|
|
Net Property, Plant & Equipment
|
0.01
|
0.02
|
0.02
|
0.02
|
|
Total Assets
|
13.50
|
1.09
|
4.07
|
4.26
|
|
Liabilities
|
|
|
|
|
|
Accounts Payable
|
2.58
|
1.73
|
1.24
|
1.27
|
|
Debt in Current Liabilities
|
NA
|
NA
|
NA
|
NA
|
|
Total Current Liabilities
|
5.20
|
1.74
|
1.25
|
1.28
|
|
Long-Term Debt
|
NA
|
NA
|
NA
|
NA
|
|
Total Liabilities
|
15.56
|
1.74
|
2.07
|
2.10
|
|
Stockholder's Equity
|
|
|
|
|
|
Minority Interest
|
NA
|
NA
|
0.80
|
0.80
|
|
Preferred Stock
|
NA
|
NA
|
NA
|
NA
|
|
Common Stock
|
62.86
|
57.96
|
52.35
|
50.16
|
|
Retained Earnings
|
-71.10
|
-63.90
|
-54.23
|
-50.47
|
|
Treasury Stock
|
NA
|
NA
|
NA
|
NA
|
|
Total Stockholders' Equity
|
-2.85
|
-1.45
|
2.00
|
2.16
|
|
Total Liabilities and Stockholders' Equity
|
12.70
|
0.29
|
4.07
|
4.26
|
Cash Flow Summary (Millions) |
|
Categories
|
12/31/2010
|
12/31/2009
|
12/31/2008
|
12/31/2007
|
|
Net Cash Provided by Operating Activities
|
7.86
|
-3.50
|
-3.28
|
-3.69
|
|
Net Cash Provided by Investing Activities
|
-0.01
|
-0.00
|
-0.23
|
-1.19
|
|
Net Cash Provided by Financing Activities
|
4.66
|
3.90
|
3.51
|
4.91
|
Annual Summary Data (Millions) |
| Year |
Sales |
Net
Income |
EPS |
| 12/2006 | 0.44 | -4.89 | -0.18 | | 12/2007 | 0.41 | -5.29 | -0.18 | | 12/2008 | 0.43 | -4.59 | -0.15 | | 12/2009 | 0.42 | -5.13 | -0.17 | | 12/2010 | 0.69 | -6.96 | -0.22 | | Growth Rates | 11.83 | -- | -- |
| Type |
Date(Q,M) |
No.
Owners |
Shares
Held (000s) |
%
Own |
| Institutional | 12/31/11 | 48 | 2,039 | 6.25 |
|
Report Date :
1/30/2012
 Copyright
2012, EDGAR Online, Inc. All
rights reserved. Replication or redistribution of EDGAR Online, Inc. content is
expressly prohibited without the prior written consent of EDGAR Online, Inc.
EDGAR Online, Inc. shall not be liable for any errors or delays in the content,
or for any actions taken in reliance thereon.
|
|
|